Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) FCF Margin (2017 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed FCF Margin for 9 consecutive years, with 64585.13% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 39940.0% to 64585.13% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 97607.42% through Dec 2025, down 4941385.0% year-over-year, with the annual reading at 97607.42% for FY2025, 4941385.0% down from the prior year.
  • FCF Margin for Q4 2025 was 64585.13% at Creative Medical Technology Holdings, down from 53051.17% in the prior quarter.
  • The five-year high for FCF Margin was 1587.82% in Q3 2022, with the low at 64984.53% in Q4 2024.
  • Average FCF Margin over 5 years is 27095.56%, with a median of 18837.0% recorded in 2024.
  • The sharpest move saw FCF Margin skyrocketed 232007bps in 2022, then tumbled -4385839bps in 2023.
  • Over 5 years, FCF Margin stood at 1714.05% in 2021, then tumbled by -1026bps to 19307.71% in 2022, then crashed by -227bps to 63166.1% in 2023, then fell by -3bps to 64984.53% in 2024, then rose by 1bps to 64585.13% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 64585.13%, 53051.17%, and 64984.53% for Q4 2025, Q1 2025, and Q4 2024 respectively.